Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Acute Effects of Resistance Exercise-Based PAPE in Adolescent Basketball Players (PAPE)

19. november 2026 oppdatert av: Mertkan Öncü, Uludag University

Acute Effects of Resistance Exercise-Based PAPE on Basketball-Specific Cognitive-Motor Dual-Task Performance in Adolescent Basketball Players: A Randomized Crossover Study

This study evaluates the acute effects of resistance exercise-based post-activation performance enhancement (PAPE) on basketball-specific cognitive-motor dual-task performance in male adolescent basketball players. Twenty-one basketball players aged 15 to 17 years complete three experimental conditions in a randomized crossover design: a standardized basketball warm-up, 5 repetitions of the back squat at 80% of individual one-repetition maximum (1RM), and 5 repetitions of the deadlift at 80% of individual 1RM. Each participant completes all three conditions with 48 hours between experimental sessions. Basketball-specific cognitive-motor dual-task performance is assessed before and after each condition using a task adapted from the NBA Draft Combine dribbling test that incorporates simultaneous motor responses to visual stimuli. The primary purpose is to compare the acute changes in performance following the two resistance exercise-based PAPE conditions with those following the standardized basketball warm-up.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

21

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Bursa
      • Bursa, Bursa, Tyrkia (Türkiye), 16000
        • Bursa Uludag University, Faculty of Sport Sciences

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

16 år til 17 år (Barn)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Mann

Beskrivelse

Inclusion Criteria:

  • Male basketball players aged 16-17 years.
  • At least two years of regular basketball training experience.
  • Ability to safely perform the back squat and deadlift exercises and complete the basketball-specific cognitive-motor dual-task test.
  • Written informed consent from a parent or legal guardian and assent from the participant.
  • No serious musculoskeletal injury affecting sports performance within the previous six months.

Exclusion Criteria:

  • Any musculoskeletal condition that prevented safe completion of the resistance exercise or basketball-specific testing procedures.
  • Inability to complete any of the experimental conditions or required performance assessments.
  • Failure to comply with the pre-session requirements, including avoidance of strenuous physical activity and caffeine consumption.
  • Withdrawal of participant assent or parental/legal guardian consent.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Standardized Basketball Warm-Up

Participants completed a standardized basketball warm-up condition. Basketball-specific cognitive-motor dual-task performance was assessed before the conditioning activity and again after the condition. This condition served as the active comparator for the two resistance exercise-based PAPE conditions.

Participants performed a standardized basketball warm-up as the active comparator condition. Basketball-specific cognitive-motor dual-task performance was assessed before the warm-up and again after completion of the condition.

Eksperimentell: Back Squat PAPE

Participants completed 5 repetitions of the back squat exercise at 80% of their individual one-repetition maximum (1RM) as a resistance exercise-based PAPE condition. Basketball-specific cognitive-motor dual-task performance was assessed before the conditioning activity and again after a 3-5-minute recovery period.

Participants performed 5 repetitions of the back squat exercise at 80% of their individual one-repetition maximum (1RM) as a resistance exercise-based PAPE conditioning activity. Following the conditioning activity, participants completed a 3-5-minute recovery period before post-intervention assessment of basketball-specific cognitive-motor dual-task performance.

Eksperimentell: Deadlift PAPE

Participants completed 5 repetitions of the deadlift exercise at 80% of their individual one-repetition maximum (1RM) as a resistance exercise-based PAPE condition. Basketball-specific cognitive-motor dual-task performance was assessed before the conditioning activity and again after a 3-5-minute recovery period.

Participants performed 5 repetitions of the deadlift exercise at 80% of their individual one-repetition maximum (1RM) as a resistance exercise-based PAPE conditioning activity. Following the conditioning activity, participants completed a 3-5-minute recovery period before post-intervention assessment of basketball-specific cognitive-motor dual-task performance.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Basketball-Specific Cognitive-Motor Dual-Task Performance
Tidsramme: Immediately before and 3-5 minutes after each experimental condition

Performance was assessed using a cognitive-motor dual-task adapted from the NBA Draft Combine dribbling test. Participants completed the basketball-specific dribbling course while simultaneously responding to visual stimuli with corresponding motor responses. Performance was recorded as task completion time in seconds using an electronic timing system. A shorter completion time indicated better performance.

Immediately before and 3-5 minutes after each experimental condition

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

26. september 2026

Primær fullføring (Faktiske)

12. oktober 2026

Studiet fullført (Faktiske)

12. oktober 2026

Datoer for studieregistrering

Først innsendt

25. september 2026

Først innsendt som oppfylte QC-kriteriene

25. september 2026

Først lagt ut (Faktiske)

1. oktober 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

20. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

19. november 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 2026/276/10-10

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Anonymized individual participant data underlying the results reported in the publication may be made available to qualified researchers upon reasonable request to the corresponding author, subject to applicable institutional and ethical restrictions.

IPD-delingstidsramme

Anonymized IPD may be made available following publication of the study results. No predetermined end date is specified; availability will be subject to applicable institutional and ethical requirements.

Tilgangskriterier for IPD-deling

Anonymized IPD may be provided to qualified researchers upon reasonable request to the corresponding author. Requests should include a scientifically appropriate purpose for the proposed use of the data. Access will be considered in accordance with applicable institutional and ethical requirements.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .